Pharmacology
Conference Coverage
Heart failure med undertreatment because of older age common, flouts evidence
The oldest less often received guideline-specified meds, especially at close to full dosage, maybe because advanced age is seen as an “intrinsic”...
News
Huge trial casts doubt on bisphosphonates for breast cancer
New results show no difference in disease-free survival, distant disease-free survival, and overall survival.
Conference Coverage
What’s best for diabetes after metformin? GRADE outdated at outset
The GRADE trial compared four different agents as add-ons to metformin for type 2 diabetes, but the study is already outdated, said one...
Conference Coverage
Nocturnal hypoglycemia halved with insulin degludec vs. glargine
Researchers pitted degludec against glargine U100 in the toughest patients with type 1 diabetes, those who had severe nocturnal hypoglycemia.
Conference Coverage
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2D
Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss.
News
FDA approves OTC antihistamine nasal spray
Nasal antihistamines “work quickly, whereas the nasal steroids don’t, and I think a lot of people who go to the drugstore looking for allergy...
Conference Coverage
Promising HER2+/HR– breast cancer survival with de-escalated therapy
News
FDA: More metformin extended-release tablets recalled
Conference Coverage
Surgical outcomes favor addition of nivolumab to neoadjuvant chemo in resectable lung cancers
News
Schizophrenia meds a key contributor to cognitive impairment
The investigators found that 63% of participants had an anticholinergic cognitive burden score of at least 3, which is "striking."